Search

Displaying results 6861 - 6870 of 10000 in total
  1. Drug

    BI 44370 TA

    go.drugbank.com/drugs/DB16037
    Investigational

    BI 44370 TA is under investigation in clinical trial NCT00751803 (BI 44370 TA in Acute Migraine Attack).

  2. Drug

    Pipazethate

    go.drugbank.com/drugs/DB08796
    Investigational

    A non-narcotic oral antitussive agent.

  3. Drug

    AT9283

    go.drugbank.com/drugs/DB05169
    Investigational

    AT9283 is an aurora Kinase inhibitor developed by Astex Therapeutics for the treatment of cancer.

  4. Drug

    ZYCOV-D

    go.drugbank.com/drugs/DB15892
    Experimental

    Once the plasmid DNA is introduced into host cells and the viral protein is translated, it elicits a strong immune response, stimulating the humoral and cellular components of the immune system[L16503] … The vaccine was developed using a DNA vaccine platform with a non-replicating and non-integrating plasmid carrying the gene of interest[L16503].

  5. Drug

    NV1020

    go.drugbank.com/drugs/DB04969
    Investigational

    NV1020, a genetically engineered herpes simplex virus, is a novel anticancer therapeutic.

  6. Drug

    Sedecamycin

    go.drugbank.com/drugs/DB21342
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Sedecamycin is a antibiotic, produced by Streptomyces strain. Sedecamycin has a monoisotopic molecular weight of 501.24 Da.

  7. Drug

    Ambasilide

    go.drugbank.com/drugs/DB19463
    Experimental

    The usage of the INN stem '-ilide' in the name indicates that Ambasilide is a sematilide derivative class III antiarrhythmic. Ambasilide has a monoisotopic molecular weight of 335.2 Da.

  8. Drug

    Bitipazone

    go.drugbank.com/drugs/DB19941
    Experimental

    The usage of the INN stem '-azone' in the name indicates that Bitipazone is a anti-inflammatory analgesic, phenylbutazone derivative. Bitipazone has a monoisotopic molecular weight of 454.27 Da.

  9. Drug

    IPH 1101

    go.drugbank.com/drugs/DB05754
    Experimental

    IPH 1101 is the most advanced drug candidate of the γδ T cell platform … IPH 1101 is a chemically-synthesized structural analog of non-conventional bacterial phosphoantigens which specifically activate the Vγ9Vδ2 T cell subset.

  10. Drug

    Cinfenoac

    go.drugbank.com/drugs/DB19485
    Experimental

    The usage of the INN stem '-ac' in the name indicates that Cinfenoac is a anti-inflammatory agent, ibufenac derivative. Cinfenoac has a monoisotopic molecular weight of 326.08 Da.